Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 1 | uM | 7 | 1250.00 | 580.08 | 1689.00 | 1791.00 | 0.9431 | 0.9292 |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 1696.00 | 1791.00 | 0.9470 | 0.9341 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 4.00 | 1791.00 | 0.0022 | -0.9531 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 2.00 | 1791.00 | 0.0011 | -0.9694 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 1644.00 | 1791.00 | 0.9179 | 0.8974 | |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 1250.00 | 580.08 | 1564.00 | 1791.00 | 0.8733 | 0.8401 |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 1250.00 | 580.08 | 1886.00 | 1791.00 | 1.0530 | 1.0646 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 1250.00 | 580.08 | 1281.00 | 1791.00 | 0.7152 | 0.6276 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 1250.00 | 580.08 | 1886.00 | 1791.00 | 1.0530 | 1.0646 |
| BT-20 | 17-AAG | 1 | uM | 7 | 1250.00 | 580.08 | 676.00 | 1791.00 | 0.3774 | 0.0987 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 1250.00 | 580.08 | 1988.00 | 1791.00 | 1.1100 | 1.1325 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 1250.00 | 580.08 | 825.00 | 1791.00 | 0.4606 | 0.2418 |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 2049.00 | 1791.00 | 1.1441 | 1.1725 | |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 1250.00 | 580.08 | 1909.00 | 1791.00 | 1.0659 | 1.0800 |
| BT-20 | 17-AAG | 0.01 | uM | 7 | 1250.00 | 580.08 | 1168.00 | 1791.00 | 0.6522 | 0.5377 |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 2048.00 | 1791.00 | 1.1435 | 1.1719 | |
| BT-20 | Erlotinib | 10 | uM | 7 | 1250.00 | 580.08 | 1397.00 | 1791.00 | 0.7800 | 0.7167 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 1250.00 | 580.08 | 1830.00 | 1791.00 | 1.0218 | 1.0267 |
| BT-20 | Lapatinib | 10 | uM | 7 | 1250.00 | 580.08 | 837.00 | 1791.00 | 0.4673 | 0.2529 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 1250.00 | 580.08 | 975.00 | 1791.00 | 0.5444 | 0.3761 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 1250.00 | 580.08 | 1958.00 | 1791.00 | 1.0932 | 1.1127 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 1250.00 | 580.08 | 2060.00 | 1791.00 | 1.1502 | 1.1797 |
| BT-20 | Lapatinib | 1 | uM | 7 | 1250.00 | 580.08 | 1588.00 | 1791.00 | 0.8867 | 0.8574 |
| BT-20 | 17-AAG | 0.1 | uM | 7 | 1250.00 | 580.08 | 639.00 | 1791.00 | 0.3568 | 0.0613 |
| BT-20 | Lapatinib | 0.01 | uM | 7 | 1250.00 | 580.08 | 1863.00 | 1791.00 | 1.0402 | 1.0491 |